Date of Last Revision

2016-11-04 04:20:13

Major

Chemistry - Biochemistry

Degree Name

Bachelor of Science

Date of Expected Graduation

Spring 2017

Abstract

Fragment-based drug design (FBDD) is a method of pharmaceutical research involving characterization of small “fragment” molecule interactions with a target protein. These fragments are optimized with the addition of a nucleophilic “warhead” moiety. Several novel fragment-warhead adducts have been synthesized in house by group member Ram Khattri Ph.D. The experiment investigates reactivity of these adducts with glutaredoxin protein (Grx) orthologs from Homo sapiens, Pseudomonas aeruginosa and Brucella melitensis. Three novel fragment-warhead adducts have been identified to cause weakly bacteriostatic and bacteriocidal effects, most with minimum inhibitory concentration values near 1.28 mg/mL. Discussed herein are molecular effects of these fragment-warhead compounds on Grx, such as their association in inducing Grx oligomerization. Further investigation of the fragment-warhead adduct coumarin acrylamide was performed due to its fluorescent properties. Use of Grx as a druggable candidate for development of a putative antibiotic has been a relatively untapped target until recently. These results may help further characterize Grx, and its ability to mediate bacterial survivability, to aid in the fight against multi-drug resistant and opportunistic bacterial infections such as pneumonia and brucellosis.

Research Sponsor

Dr. Thomas Leeper

First Reader

Dr. Wiley Youngs

Second Reader

Dr. Claire Tessier

Included in

Biochemistry Commons

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.